NCT 04305054 Brief Summary Substudy 02B is part of a larger…
Read more arrow_forwardNCT 04031677 Brief Summary This is a multicenter, randomized, open label…
Read more arrow_forwardNCT 04261855 Brief Summary 10.17 GoTHAM is intended as a signal-seeking, biomarker,…
Read more arrow_forwardNCT 05549297 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04585750 Brief Summary The Phase 2 monotherapy portion of this…
Read more arrow_forwardNCT 05756322 Brief Summary The most common types of acute leukaemia are…
Read more arrow_forwardNCT 03456843 Brief Summary This randomized phase II trial studies how well…
Read more arrow_forwardNCT 05356741 Brief Summary This first-in-human (FIH) Phase 1 open-label multicenter dose-escalation…
Read more arrow_forwardNCT 05411133 Brief Summary This study aims to find out: The tolerability…
Read more arrow_forwardNCT 05788081 Brief Summary First line treatment with combination rituximab and golcadomide…
Read more arrow_forward